Effects of N‑Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior

• Published in: ACS chemical neuroscience Vol. 9; no. 7; pp. 1829 - 1839
• Main Authors: Battisti, Umberto M, Sitta, Ramsey, Harris, Alan, Sakloth, Farhana, Walther, Donna, Ruchala, Iwona, Negus, S. Stevens, Baumann, Michael H, Glennon, Richard A, Eltit, Jose M
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 18.07.2018
• Subjects: Amphetamine-Related Disorders - metabolism; Animals; Behavior, Animal - drug effects; Brain - drug effects; Brain - metabolism; Calcium - metabolism; Central Nervous System Agents - chemical synthesis; Central Nervous System Agents - chemistry; Central Nervous System Agents - pharmacology; Disease Models, Animal; HEK293 Cells; Humans; Isomerism; Male; Methamphetamine - chemical synthesis; Methamphetamine - chemistry; Methamphetamine - pharmacology; Molecular Structure; Rats, Sprague-Dawley; Symporters - metabolism; Synaptosomes - drug effects; Synaptosomes - metabolism; Mephedrone; norepinephrine transporter (NET); drug abuse; dopamine transporter (DAT); amphetamine; ICSS; bath salts; serotonin transporter (SERT); synthetic cathinones
• ISSN: 1948-7193; 1948-7193
• DOI: 10.1021/acschemneuro.8b00138

4-Methylamphetamine (4-MA) is an emerging drug of abuse that acts as a substrate at plasma membrane transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT), thereby causing nonexocytotic release of monoamine transmitters via reverse transport. Prior studies by us showed that increasing the N-alkyl chain length of N-substituted 4-MA analogues converts 4-MA from a transportable substrate (i.e., releaser) at DAT and NET to a nontransported blocker at these sites. Here, we studied the effects of the individual optical isomers of N-methyl-, N-ethyl-, and N-n-propyl 4-MA on monoamine transporters and abuse-related behavior in rats because action/function might be related to stereochemistry. Uptake inhibition and release assays were conducted in rat brain synaptosomes whereas electrophysiological assessments of drug–transporter interactions were examined using cell-based biosensors. Intracranial-self-stimulation in rats was employed to assess abuse potential in vivo. The experimental evidence demonstrates that S(+)N-methyl 4-MA is a potent and efficacious releaser at DAT, NET, and SERT with the highest abuse potential among the test drugs, whereas R(−)N-methyl 4-MA is a less potent releaser with reduced abuse potential. The S(+)­ethyl analogue has decreased efficacy as a releaser at DAT but retains full release activity at NET and SERT with a reduction in abuse-related effects; the R(−)­ethyl analogue has a similar profile but is less potent. S(+)N-Propyl 4-MA is a nontransported blocker at DAT and NET but an efficacious releaser at SERT, whereas the R enantiomer is almost inactive. In conclusion, the S enantiomers of the N-alkyl 4-MA analogues are most potent. Lengthening the N-alkyl chain converts compounds from potent nonselective releasers showing abuse-related effects to more selective SERT releasers with no apparent abuse potential.